Skip to content

Clinical trials

Phase 2 Cholangiocarcinoma trials in France

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Cholangiocarcinoma Phase: Phase 2 Country / region: France Clear all

14 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20091
20111
20131
20151
20172
20181
20192
20211
20231
20252
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed7
Recruiting3
Terminated2
Active, not recruiting1
Not yet recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Basilea Pharmaceutica1
Center Eugene Marquis1
EMD Serono Research & Development Institute, Inc.1
Federation Francophone de Cancerologie Digestive1
Fore Biotherapeutics1
GERCOR - Multidisciplinary Oncology Cooperative Group1
Hoffmann-La Roche1
Incyte Corporation1
Jules Bordet Institute1
Merck Sharp & Dohme LLC1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Cholangiocarcinoma14
Biliary Tract Neoplasms4
Ovarian Neoplasms3
Bile Duct Neoplasms2
Breast Neoplasms2
Carcinoma, Hepatocellular2
Endometrial Neoplasms2
Gallbladder Neoplasms2
Urinary Bladder Neoplasms2
Acrocephalosyndactylia1

Trials

Showing 1 to 14 of 14. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.